1. Chang SM, Parney IF, Huang W, Anderson FAJ, Asher AL, Bernstein M, Lillehei KO, Brem H, Berger MS, Laws ER (2005) Glioma outcomes project investigators patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:2469–2470
2. Attenello FJ, Mukherjee D, Datoo G, McGirt MJ, Bohan E, Weingart JD, Olivi A, Quinones-Hinojosa A, Brem H (2008) BCNU wafer in surgical treatment of glioma. Ann Surg Oncol 15:2887–2893
3. Gururangan S, Cokgor L, Rich JN, Edwards S, Affronti ML, Quinn JA, Herndon JEn, Provenzale JM, McLendon RE, Tourt-Uhlig S, Sampson JH, Stafford-Fox V, Zaknoen S, Early M, Friedman AH, Friedman HS (2001) Phase I study of gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. Neuro Oncol 3:246–250
4. La Rocca R, Vitaz TW, Villanueva W, Hodes J, Cervera A, New P, Litofsky N (2008) A phase 2 study of multi-modal therapy with surgery, carmustine (BCNU) wafer, radiation therapy (RT), and temozolomide (TMZ) in patients (PTS) with newly diagnosed supratentorial malignant glioma (MG). In: 8th Congress of the European association of neurooncology. Barcelona, Spain
5. McGirt MJ, Than KD, Weingart JD, Chaichana KL, Attenello F, Olivi O, Laterra J, Kleinberg LR, Grossman SA, Brem H, Quinones-Hinojosa A (2008) Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg 110:583–588